Assessment of quality and clinical effectiveness of apheresis platelet concentrates treated with mirasol pathogen reduction system in plasma or in platelet additive solution SSP

被引：0
|
作者：
Ignatova, A. [1 ]
Karpova, O. [1 ]
Trahtman, P. [1 ]
Rumyantsev, S. [1 ]
Panteleev, M. [1 ]
机构：
[1] Fed Res & Clin Ctr Pediat Hematol Oncol & Immunol, Moscow, Russia
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2015年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PO569-MON
引用
收藏
页码：467 / 468
页数：2
相关论文
共 50 条
  • [1] The effect of pathogen reduction technology (Mirasol) on platelet quality when treated in additive solution with low plasma carryover
    Johnson, L.
    Winter, K. M.
    Reid, S.
    Hartkopf-Theis, T.
    Marschner, S.
    Goodrich, R. P.
    Marks, D. C.
    [J]. VOX SANGUINIS, 2011, 101 (03) : 208 - 214
  • [2] The Mirasol® Pathogen Reduction Technology system and quality of platelets stored in platelet additive solution
    Reikvam, Hakon
    Marschner, Susanne
    Apelseth, Torunn Oveland
    Goodrich, Ray
    Hervig, Tor
    [J]. BLOOD TRANSFUSION, 2010, 8 (03) : 186 - 192
  • [3] Clinical effectiveness of leucoreduced, pooled donor platelet concentrates, stored in plasma or additive solution with and without pathogen reduction
    Kerkhoffs, Jean-Louis H.
    van Putten, Wim L. J.
    Novotny, Viera M. J.
    Boekhorst, Peter A. W. Te
    Schipperus, Martin R.
    Zwaginga, Jaap Jan
    van Pampus, Lizzy C. M.
    de Greef, Georgine E.
    Luten, Marleen
    Huijgens, Peter C.
    Brand, Anneke
    van Rhenen, Dick J.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2010, 150 (02) : 209 - 217
  • [4] Neutrophil Priming Activity in Platelet Concentrates (PCs) Collected by Apheresis and Treated with Mirasol® Pathogen Reduction Technology (PRT)
    Ambruso, D. R.
    Thurman, G.
    Tran, K.
    Marschner, S.
    Goodrich, R. P.
    [J]. TRANSFUSION, 2009, 49 : 9A - 9A
  • [5] Analysis of platelets treated with Mirasol® Pathogen Reduction Technology and stored in platelet additive solution (PAS)
    Marschner, S.
    Cardigan, R.
    Cookson, P.
    de Korte, Dirk
    Dumont, Larry J.
    Einarson, M.
    Herschel, L.
    Janetzko, K.
    Vassallo, R.
    Goodrich, R.
    [J]. TRANSFUSION, 2008, 48 (02) : 148A - 148A
  • [6] Functional characteristics and clinical effectiveness of platelet concentrates treated with riboflavin and ultraviolet light in plasma and in platelet additive solution
    Ignatova, A. A.
    Karpova, O. V.
    Trakhtman, P. E.
    Rumiantsev, S. A.
    Panteleev, M. A.
    [J]. VOX SANGUINIS, 2016, 110 (03) : 244 - 252
  • [7] Comparison of apheresis platelet concentrates stored in platelet additive solution and in autologous plasma, respectively
    Stiegler, G
    Leitner, G
    Hoecker, P
    [J]. TRANSFUSION, 2001, 41 (09) : 48S - 48S
  • [8] Treatment of Buffy Coat Platelets in Platelet Additive Solution with the Mirasol® Pathogen Reduction Technology System
    Castrillo, Azucena
    Cardoso, Marcia
    Rouse, Lindsay
    [J]. TRANSFUSION MEDICINE AND HEMOTHERAPY, 2013, 40 (01) : 44 - 48
  • [9] Analysis of plasma ratio and cell quality of platelet hyperconcentrates treated with mirasol® pathogen reduction technology
    Marschner, S.
    Buytaert-Hoefen, K. A.
    Hovenga, N. A.
    Dumont, D. F.
    Herschel, L. H.
    Roger, J.
    Dumont, L. J.
    Aubuchon, J. P.
    Goodrich, R. P.
    [J]. TRANSFUSION, 2007, 47 (03) : 81A - 81A
  • [10] IN VITRO CELL QUALITY OF ATREUS® 3C DERIVED PLATELET CONCENTRATES TREATED WITH THE MIRASOL® PATHOGEN REDUCTION TECHNOLOGY SYSTEM
    Maia, S.
    Ramoa, A.
    Pacheco, R.
    Ruivo, I
    van Waeg, G.
    [J]. VOX SANGUINIS, 2010, 99 : 245 - 245
12345